Cargando…
Focal bone lesions in hiv-positive patient treated with tenofovir
BACKGROUND: Tenofovir is a widely used antiviral drug for the treatment of HIV and HBV infection. Although its side effects on renal function and bone metabolism are well known, there are no reports on focal bone lesions caused by this drug. Our case suggests this new, unusual but important scenario...
Autores principales: | Mangioni, Davide, Bandera, Alessandra, Muscatello, Antonio, Squillace, Nicola, Crivellaro, Cinzia, Guerra, Luca, Messa, Cristina, Gori, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975803/ https://www.ncbi.nlm.nih.gov/pubmed/24602357 http://dx.doi.org/10.1186/1471-2334-14-131 |
Ejemplares similares
-
Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
por: Squillace, Nicola, et al.
Publicado: (2018) -
The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery
por: Bandera, Alessandra, et al.
Publicado: (2018) -
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
por: Lombardi, Andrea, et al.
Publicado: (2021) -
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
por: Crivellaro, Cinzia, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
por: Castelli, Valeria, et al.
Publicado: (2021)